✦ LIBER ✦

1195 BMS-650032, AN NS3 INHIBITOR, IN COMBINATION WITH PEGINTERFERON ALPHA-2A AND RIBAVIRIN IN TREATMENT-NAIVE SUBJECTS WITH GENOTYPE 1 CHRONIC HEPATITIS C INFECTION

✍ Scribed by Bronowicki, J.-P.; Pol, S.; Thuluvath, P.J.; Larrey, D.; Martorell, C.T.; Rustgi, V.K.; Morris, D.W.; Younes, Z.; Fried, M.W.; Bourliere, M.; Hezode, C.; Massoud, O.; Abrams, G.A.; Ratziu, V.; Thiry, A.; Llamoso, C.; Hughes, E.A.; Hindes, R.G.

Book ID: 123006062
Publisher: Elsevier Science
Year: 2011
Tongue: English
Weight: 46 KB
Volume: 54
Category: Article
ISSN: 0168-8278
DOI: 10.1016/S0168-8278(11)61197-5

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

1096 ASUNAPREVIR (ASV; BMS-650032), AN N

1096 ASUNAPREVIR (ASV; BMS-650032), AN NS3 PROTEASE INHIBITOR, IN COMBINATION WITH PEGINTERFERON AND RIBAVIRIN IN TREATMENT-NAIVE PATIENTS WITH GENOTYPE 1 CHRONIC HEPATITIS C INFECTION

✍ Bronowicki, J.-P.; Pol, S.; Thuluvath, P.; Larrey, D.; Martorell, C.T.; Rustgi, 📂 Article 📅 2012 🏛 Elsevier Science 🌐 English ⚖ 72 KB

1163 A PHASE 2A STUDY OF BMS-791325, AN

1163 A PHASE 2A STUDY OF BMS-791325, AN NS5B POLYMERASE INHIBITOR, WITH PEGINTERFERON ALFA-2A AND RIBAVIRIN IN TREATMENT-NAIVE PATIENTS WITH GENOTYPE 1 CHRONIC HEPATITIS C INFECTION

✍ Tatum, H.; Thuluvath, P.; Lawitz, E.; Martorell, C.T.; Demicco, M.; Cohen, S.; R 📂 Article 📅 2012 🏛 Elsevier Science 🌐 English ⚖ 58 KB

Efficacy of boceprevir, an NS3 protease

Efficacy of boceprevir, an NS3 protease inhibitor, in combination with peginterferon alfa-2b and ribavirin in treatment-naive patients with genotype 1 hepatitis C infection (SPRINT-1): an open-label, randomised, multicentre phase 2 trial

✍ Paul Y Kwo; Eric J Lawitz; Jonathan McCone; Eugene R Schiff; John M Vierling; Da 📂 Article 📅 2010 🏛 The Lancet 🌐 English ⚖ 378 KB

Treatment of insulin resistance with met

Treatment of insulin resistance with metformin in naïve genotype 1 chronic hepatitis C patients receiving peginterferon alfa-2a plus ribavirin

✍ Manuel Romero-Gómez; Moisés Diago; Raúl J. Andrade; José L. Calleja; Javier Salm 📂 Article 📅 2009 🏛 John Wiley and Sons 🌐 English ⚖ 309 KB 👁 1 views

Insulin resistance affects sustained virological response (SVR) in chronic hepatitis C. To know whether adding metformin to standard antiviral treatment improves SVR, we conducted a prospective, multicentered, randomized, double-blinded, placebo-controlled trial in 19 Spanish hospitals, including 12

14 DUAL ORAL THERAPY WITH THE NS5A INHIB

14 DUAL ORAL THERAPY WITH THE NS5A INHIBITOR DACLATASVIR (BMS-790052) AND NS3 PROTEASE INHIBITOR ASUNAPREVIR (BMS-650032) IN HCV GENOTYPE 1B-INFECTED NULL RESPONDERS OR INELIGIBLE/INTOLERANT TO PEGINTERFERON/RIBAVIRIN

✍ F. Suzuki; K. Ikeda; J. Toyota; Y. Karino; T. Ohmura; K. Chayama; S. Takahashi; 📂 Article 📅 2012 🏛 Elsevier Science 🌐 English ⚖ 117 KB

Randomized Controlled Trial of Danoprevi

Randomized Controlled Trial of Danoprevir Plus Peginterferon Alfa-2a and Ribavirin in Treatment-Naïve Patients With Hepatitis C Virus Genotype 1 Infection

✍ Marcellin, Patrick; Cooper, Curtis; Balart, Luis; Larrey, Dominique; Box, Terry; 📂 Article 📅 2013 🏛 Elsevier Science 🌐 English ⚖ 517 KB